The new SARS-CoV-2 virus is an RNA virus that belongs to the Coronaviridae family and
causes COVID-19 disease. The newly sequenced virus appears to originate in China and …

The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

The rapid surge of SARS-CoV-2 cases due to the 'variant of concern (VOC) 202012/01', also
known as lineage B. 1.1. 7 or 20B/501Y. V1 in the UK, 1 in December 2020, raised concerns …

Multiple preventive vaccines are being developed to counter the coronavirus disease 2019
pandemic. The leading candidates have now been evaluated in nonhuman primates (NHPs) …

It is striking that all marketed SARS-CoV-2 vaccines are developed for intramuscular
administration designed to produce humoral and cell mediated immune responses …

Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …

What do we know about India’s Covaxin vaccine? Page 1 COVID-19 VACCINES What do we
know about India’s Covaxin vaccine? India has rapidly approved and rolled out Covaxin, its …

Background Different forms of vaccines have been developed to prevent the SARS‐CoV‐2
virus and subsequent COVID‐19 disease. Several are in widespread use globally …

The coronavirus SARS-CoV-2, which causes Coronavirus disease 2019 (COVID-19), has
infected more than 100 million people globally and caused over 2.5 million deaths in just …

Since the outbreak of the COVID-19 pandemic, there has been a rapid expansion in vaccine
research focusing on exploiting the novel discoveries on the pathophysiology, genomics …